The Asia Pacific Gene Synthesis Market is expected to witness market growth of 18.0% CAGR during the forecast period (2021-2027).
The gene synthesis method increases the capabilities for new biological functionality that encouraged the arrival of supportive government protocols related to gene synthesis as well as the rest of the synthetic biology. Also, the emergence of various start-ups and forums is motivating the researchers and analysts to analyze the concepts comprehending to gene synthesis. Moreover, it is contributing to the development of new technologies.
Large molecules in cells are established with genetic data and can be simply identified through the chemical synthesis of proteins and nucleic acids. The concept of gene synthesis is aggressively being utilized in past years and has become a highly flexible and strong molecule engineering method for artificial DNA synthesis.
APAC is a region with a huge number of ongoing as well as completed researches. Also, a huge number of people are being diagnosed with various variants of cancer. Few of these can be cured with the help of synthetic biology practices. Moreover, the rising scale of the geriatric population across the region is expected to further need DNA replication due to the various diseases and disorders that occur in the old age and can be cured by diagnosis and treatment processes under gene synthesis practices.
The China market dominated the Asia Pacific Gene Synthesis Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $395.7 million by 2027. The Japan market is experiencing a CAGR of 17.3% during (2021 - 2027). Additionally, The India market is expected to showcase a CAGR of 18.8% during (2021 - 2027).
Based on Method, the market is segmented into Solid-phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis. Based on Service Type, the market is segmented into Antibody DNA Synthesis, Viral DNA Synthesis and Others. Based on Application, the market is segmented into Gene & Cell Therapy Development, Vaccine Development, Disease Diagnosis and Others. Based on End User, the market is segmented into Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies and Contract Research Organizations. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Genscript Biotech Corporation, Thermo Fisher Scientific, Inc., Brooks Automation, Inc., Boster Biological Technology, Twist Bioscience Corporation, Danaher Corporation, Biomatik Corporation, ProteoGenix, ProMab Biotechnologies, Inc., and OriGene Technologies, Inc.
The gene synthesis method increases the capabilities for new biological functionality that encouraged the arrival of supportive government protocols related to gene synthesis as well as the rest of the synthetic biology. Also, the emergence of various start-ups and forums is motivating the researchers and analysts to analyze the concepts comprehending to gene synthesis. Moreover, it is contributing to the development of new technologies.
Large molecules in cells are established with genetic data and can be simply identified through the chemical synthesis of proteins and nucleic acids. The concept of gene synthesis is aggressively being utilized in past years and has become a highly flexible and strong molecule engineering method for artificial DNA synthesis.
APAC is a region with a huge number of ongoing as well as completed researches. Also, a huge number of people are being diagnosed with various variants of cancer. Few of these can be cured with the help of synthetic biology practices. Moreover, the rising scale of the geriatric population across the region is expected to further need DNA replication due to the various diseases and disorders that occur in the old age and can be cured by diagnosis and treatment processes under gene synthesis practices.
The China market dominated the Asia Pacific Gene Synthesis Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $395.7 million by 2027. The Japan market is experiencing a CAGR of 17.3% during (2021 - 2027). Additionally, The India market is expected to showcase a CAGR of 18.8% during (2021 - 2027).
Based on Method, the market is segmented into Solid-phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis. Based on Service Type, the market is segmented into Antibody DNA Synthesis, Viral DNA Synthesis and Others. Based on Application, the market is segmented into Gene & Cell Therapy Development, Vaccine Development, Disease Diagnosis and Others. Based on End User, the market is segmented into Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies and Contract Research Organizations. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Genscript Biotech Corporation, Thermo Fisher Scientific, Inc., Brooks Automation, Inc., Boster Biological Technology, Twist Bioscience Corporation, Danaher Corporation, Biomatik Corporation, ProteoGenix, ProMab Biotechnologies, Inc., and OriGene Technologies, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Method
- Solid-phase Synthesis
- Chip-based Synthesis and
- PCR-based Enzyme Synthesis
By Service Type
- Antibody DNA Synthesis
- Viral DNA Synthesis and
- Others
By Application
- Gene & Cell Therapy Development
- Vaccine Development
- Disease Diagnosis and
- Others
By End User
- Academic & Government Research Institutes
- Biotechnology & Pharmaceutical Companies and
- Contract Research Organizations
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Genscript Biotech Corporation
- Thermo Fisher Scientific, Inc.
- Brooks Automation, Inc.
- Boster Biological Technology
- Twist Bioscience Corporation
- Danaher Corporation
- Biomatik Corporation
- ProteoGenix
- ProMab Biotechnologies, Inc.
- OriGene Technologies, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. Asia Pacific Gene Synthesis Market by Method
Chapter 5. Asia Pacific Gene Synthesis Market by Service Type
Chapter 6. Asia Pacific Gene Synthesis Market by Application
Chapter 7. Asia Pacific Gene Synthesis Market by End User
Chapter 8. Asia Pacific Gene Synthesis Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Genscript Biotech Corporation
- Thermo Fisher Scientific, Inc.
- Brooks Automation, Inc.
- Boster Biological Technology
- Twist Bioscience Corporation
- Danaher Corporation
- Biomatik Corporation
- ProteoGenix
- ProMab Biotechnologies, Inc.
- OriGene Technologies, Inc.
Methodology
LOADING...
